x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DIA-0230862
| Product Information | |
|---|---|
| CAS No. | 96192-35-7 |
| Synonyms | Fructoselysine dihydrochloride |
| Formula | C12H26Cl2N2O7 |
| Molecular Weight | 381.25 |
| Target | Estrogen Receptor/ERR |
| Product Description | Fructosyl-lysine (Fructoselysine) dihydrochloride is an amadori glycation product from the reaction of glucose and lysine by the Maillard reaction. Fructosyl-lysine dihydrochloride is the precursor to glucosepane, a lysine–arginine protein cross-link that can be an indicator in diabetes detection. |
| Format & Storage | |
|---|---|
| Format | Solid |
| Purity | > 95% |
| Shipping | Shipped on dry ice. |
| Storage | 4 °C, protect from light, stored under nitrogen *In solvent : -80 °C, 6 months; -20 °C, 1 month (protect from light, stored under nitrogen) |
| Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
